Clinical Neuropathological Conference
Dis Nerv Syst 34:263, Aronson,S.,et al, 1973
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
Detection of 14-3-3 Protein in Cerebrospinal Fluid Supports Dx of Creutzfeldt-Jakob Disease
Ann Neurol 43:32-40, Zerr,I.,et al, 1998
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
The 14-3-3 Brain Protein and Transmissible Spongiform Encephalopathy
NEJM 336:873-875, Moussavian,M.,et al, 1997
Detection of 14-3-3 Protein in the CSF of Genetic Creutzfeldt-Jakob Disease
Neurol 49:593-595, Rosemann,H.,et al, 1997
The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
NEJM 335:924-930, 9631996., Hsich,G.,et al, 1996
Diagnosis of Creutzfeldt-Jakob Disease in Two-Dimensional Gel Electrophoresis of Cerebrospinal Fluid
Lancet 348:846-849, Zerr,I.,et al, 1996
Creutzfeldt-Jakob Disease Following Pituitary-Derived Human Growth Hormone Therapy:A New American Case
Neurol 38:1131-1133, Marzewski,D.J.,et al, 1988
Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease
NEJM 315:279-283, Harrington,M.G.,et al, 1986
Herpes Type 2 Meningitis Following Herpes Progenitalis
West J Med 123:490, VonHoff,D.D.,et al, 1975